U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Feraheme (ferumoxytol) Information
  1. Postmarket Drug Safety Information for Patients and Providers

Feraheme (ferumoxytol) Information

Feraheme is a prescription medicine used to treat iron-deficiency anemia in adults with chronic kidney disease. It works by replenishing iron so that the body can make more red blood cells that carry oxygen throughout the body. Feraheme is given as an intravenous infusion by a health care professional in a hospital, outpatient clinic, or medical office.

Related Information

Back to Top